Assessing the impact of airway allergic diseases on children's and parents' quality of life
Official title: The Impact of Airway Allergic Diseases on the Health-related Quality of Life of Children and Their Parents (Caregivers): A Prospective Controlled Study
Run by RenJi Hospital · NCT06535087 · Data updated 2026-11-12
This study looks at how having asthma or allergies affects the quality of life for children and their parents, comparing those getting special treatment to those on regular care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 5 Years to 16 Years |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | RenJi Hospital Academic / other |
| Drugs / interventions | immunotherapy |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | July 20, 2024 |
| Main results expected | June 23, 2025 |
| Study ends | May 31, 2027 |
| Registry record updated | August 2, 2024 |
| Trial ID | NCT06535087 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children aged 5-16 diagnosed with bronchial asthma, allergic rhinitis, or both, along with their primary caregivers.
✕Probably not a fit
Patients who have already received specific immunotherapy at another hospital or those unable to complete the questionnaires may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the health-related quality of life (HRQoL) of 200 children aged 5-16 with bronchial asthma, allergic rhinitis, or both, alongside their parents. It compares 100 children receiving specific immunotherapy to 100 receiving routine treatment, using validated questionnaires to assess changes in HRQoL over one and two years. A control group of 100 healthy children and their parents will also be included to analyze the impact of allergic diseases on quality of life and caregiver burden. The study aims to provide insights that could enhance clinical management and inform policy for pediatric allergic conditions.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies that enhance the quality of life for children with allergic diseases and their families.
How similar studies have gone: Previous studies have shown that allergen-specific immunotherapy can significantly improve quality of life in patients with allergic diseases, suggesting a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Children: 1. Aged 5-16 years; 2. Diagnosed with bronchial asthma, allergic rhinitis, or both (persistent, duration ≥4 weeks) by a respiratory or allergy specialist; 3. Guardian has signed the informed consent form; 4. Able to understand and complete the questionnaire; 5. Outpatients or inpatients at the Pediatrics Department of Renji Hospital in Shanghai. 2. Parents: 1. The primary caregiver of the enrolled child; 2. Accompanied the child to the hospital on the day of the visit; 3. Signed the informed consent form; 4. Able to understand and complete the questionnaire. Exclusion Criteria: 1. Children: 1. Poor compliance; 2. Already received specific immunotherapy at another hospital; 3. Unable to independently read and complete the questionnaire; 4. Lost to follow-up or discontinued treatment. 2. Parents: 1. Unwilling to sign the informed consent form; 2. Unable to complete the questionnaire due to physical condition or educational level.
Where it's running
-
Renji Hospital, School of Medicine, Shanghai Jiaotong University
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Principal investigator: Wenjing Zhou — Renji Hospital, School of Medicine, Shanghai Jiaotong University
- Study coordinator: Wenjing Zhou
- Email: zhoujing2188@163.com
- Phone: +31685281032
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PollenVax for mugwort pollen allergy
This Phase 2 study tests PollenVax, a quick-course subcutaneous immunotherapy, in adults with mugwort pollen–triggered allergic rhinitis.
-
Home Medentum Diagnostik device for children with asthma and ear and throat problems
This project will try a multisensor Medentum Diagnostik device and app with AI to help diagnose asthma flare-ups, ear infections, and strep throat in children ages 3–17 by comparing telehealth-supported home use to usual in-person care.
-
Humidity and Mold—Healthy Home Interventions for Kids with Asthma
This study tests whether affordable home humidity control and mold-reduction measures can help reduce asthma symptoms in children with asthma.
-
Using lung ultrasound and breathing-volume measurements to improve care for infants with lower respiratory infections
This project will try lung ultrasound and tidal-flow volume measurements to see if they give clearer, objective information for infants and young children with lower respiratory infections.
-
Airports, Air Quality, and Children's Asthma Near SeaTac Airport
This trial tests whether putting HEPA portable air cleaners in homes helps reduce indoor pollution and improve asthma health for children aged 6–12 who live near SeaTac Airport.
-
WE CARE social needs screening and referral for families in primary care
This project will test whether using the WE CARE social needs screening and referral program with an antiracist approach in family medicine can help reduce chronic conditions like diabetes, high blood pressure, depression, high cholesterol, and pediatric asthma for minoritized patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.